ARTICLE | Company News
AstraZeneca sales and marketing update
September 26, 2016 7:00 AM UTC
Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) said in a dossier assessment that there is “no added benefit” for Brilique ticagrelor from AstraZeneca in combination with a low-...